nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—CYP3A4—bone cancer	0.478	1	CbGaD
Caffeine—CYP1B1—Doxorubicin—bone cancer	0.0547	0.472	CbGbCtD
Caffeine—CYP2C9—Cisplatin—bone cancer	0.0144	0.124	CbGbCtD
Caffeine—ABCB1—Cisplatin—bone cancer	0.014	0.121	CbGbCtD
Caffeine—ABCB1—Doxorubicin—bone cancer	0.00938	0.0808	CbGbCtD
Caffeine—ABCB1—Methotrexate—bone cancer	0.00909	0.0783	CbGbCtD
Caffeine—CYP2D6—Doxorubicin—bone cancer	0.00884	0.0762	CbGbCtD
Caffeine—CYP3A4—Doxorubicin—bone cancer	0.00562	0.0484	CbGbCtD
Caffeine—Necrotising colitis—Epirubicin—bone cancer	0.00382	0.109	CcSEcCtD
Caffeine—Necrotising colitis—Doxorubicin—bone cancer	0.00353	0.101	CcSEcCtD
Caffeine—ATM—connective tissue—bone cancer	0.00113	0.0766	CbGeAlD
Caffeine—Impaired healing—Methotrexate—bone cancer	0.00109	0.031	CcSEcCtD
Caffeine—Infection—Carboplatin—bone cancer	0.00104	0.0295	CcSEcCtD
Caffeine—PIK3CD—connective tissue—bone cancer	0.001	0.068	CbGeAlD
Caffeine—PIK3CB—connective tissue—bone cancer	0.000876	0.0593	CbGeAlD
Caffeine—PIK3CA—connective tissue—bone cancer	0.000867	0.0587	CbGeAlD
Caffeine—ATM—bone marrow—bone cancer	0.000754	0.051	CbGeAlD
Caffeine—PRKDC—tendon—bone cancer	0.000736	0.0498	CbGeAlD
Caffeine—PRKDC—bone marrow—bone cancer	0.000713	0.0483	CbGeAlD
Caffeine—PRKDC—spinal cord—bone cancer	0.00071	0.048	CbGeAlD
Caffeine—Deafness—Cisplatin—bone cancer	0.000695	0.0198	CcSEcCtD
Caffeine—PIK3CD—bone marrow—bone cancer	0.000669	0.0453	CbGeAlD
Caffeine—PIK3CD—spinal cord—bone cancer	0.000666	0.0451	CbGeAlD
Caffeine—Hypercalcaemia—Epirubicin—bone cancer	0.000633	0.018	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Cisplatin—bone cancer	0.000622	0.0177	CcSEcCtD
Caffeine—PIK3CB—tendon—bone cancer	0.000602	0.0408	CbGeAlD
Caffeine—RYR1—tendon—bone cancer	0.000596	0.0403	CbGeAlD
Caffeine—PIK3CA—tendon—bone cancer	0.000596	0.0403	CbGeAlD
Caffeine—Irritability—Cisplatin—bone cancer	0.000593	0.0169	CcSEcCtD
Caffeine—Hypercalcaemia—Doxorubicin—bone cancer	0.000586	0.0167	CcSEcCtD
Caffeine—PIK3CB—bone marrow—bone cancer	0.000583	0.0395	CbGeAlD
Caffeine—Blood creatinine increased—Cisplatin—bone cancer	0.000583	0.0166	CcSEcCtD
Caffeine—PIK3CB—spinal cord—bone cancer	0.000581	0.0393	CbGeAlD
Caffeine—PIK3CA—bone marrow—bone cancer	0.000577	0.0391	CbGeAlD
Caffeine—PIK3CA—spinal cord—bone cancer	0.000575	0.0389	CbGeAlD
Caffeine—Renal failure—Cisplatin—bone cancer	0.000471	0.0134	CcSEcCtD
Caffeine—Creatinine increased—Epirubicin—bone cancer	0.000462	0.0132	CcSEcCtD
Caffeine—Creatinine increased—Doxorubicin—bone cancer	0.000428	0.0122	CcSEcCtD
Caffeine—Urine output increased—Methotrexate—bone cancer	0.000425	0.0121	CcSEcCtD
Caffeine—Pulmonary oedema—Methotrexate—bone cancer	0.000418	0.0119	CcSEcCtD
Caffeine—Sepsis—Methotrexate—bone cancer	0.000408	0.0116	CcSEcCtD
Caffeine—Cardiac disorder—Cisplatin—bone cancer	0.000399	0.0114	CcSEcCtD
Caffeine—Pulmonary oedema—Epirubicin—bone cancer	0.000392	0.0112	CcSEcCtD
Caffeine—Immune system disorder—Cisplatin—bone cancer	0.000389	0.0111	CcSEcCtD
Caffeine—Sepsis—Epirubicin—bone cancer	0.000382	0.0109	CcSEcCtD
Caffeine—Malnutrition—Cisplatin—bone cancer	0.000374	0.0107	CcSEcCtD
Caffeine—Pulmonary oedema—Doxorubicin—bone cancer	0.000362	0.0103	CcSEcCtD
Caffeine—Sepsis—Doxorubicin—bone cancer	0.000353	0.0101	CcSEcCtD
Caffeine—ADORA2A—spinal cord—bone cancer	0.000352	0.0238	CbGeAlD
Caffeine—Hypoglycaemia—Epirubicin—bone cancer	0.000327	0.00932	CcSEcCtD
Caffeine—Irritability—Methotrexate—bone cancer	0.000326	0.00927	CcSEcCtD
Caffeine—Convulsion—Cisplatin—bone cancer	0.000324	0.00924	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.000319	0.00909	CcSEcCtD
Caffeine—ADORA1—tendon—bone cancer	0.000315	0.0213	CbGeAlD
Caffeine—ADORA1—spinal cord—bone cancer	0.000304	0.0206	CbGeAlD
Caffeine—Infection—Cisplatin—bone cancer	0.000304	0.00865	CcSEcCtD
Caffeine—Hypoglycaemia—Doxorubicin—bone cancer	0.000303	0.00862	CcSEcCtD
Caffeine—Nervous system disorder—Cisplatin—bone cancer	0.0003	0.00853	CcSEcCtD
Caffeine—Blood creatinine increased—Epirubicin—bone cancer	0.000299	0.00852	CcSEcCtD
Caffeine—Tachycardia—Cisplatin—bone cancer	0.000298	0.00849	CcSEcCtD
Caffeine—Skin disorder—Cisplatin—bone cancer	0.000297	0.00845	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.000295	0.00841	CcSEcCtD
Caffeine—Dry skin—Epirubicin—bone cancer	0.000293	0.00834	CcSEcCtD
Caffeine—CYP1B1—connective tissue—bone cancer	0.000291	0.0197	CbGeAlD
Caffeine—Gastritis—Epirubicin—bone cancer	0.000283	0.00805	CcSEcCtD
Caffeine—Blood creatinine increased—Doxorubicin—bone cancer	0.000277	0.00788	CcSEcCtD
Caffeine—Dyspnoea—Cisplatin—bone cancer	0.000272	0.00776	CcSEcCtD
Caffeine—Dry skin—Doxorubicin—bone cancer	0.000271	0.00771	CcSEcCtD
Caffeine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000264	0.00751	CcSEcCtD
Caffeine—Infestation—Methotrexate—bone cancer	0.000263	0.00749	CcSEcCtD
Caffeine—Infestation NOS—Methotrexate—bone cancer	0.000263	0.00749	CcSEcCtD
Caffeine—Gastritis—Doxorubicin—bone cancer	0.000261	0.00745	CcSEcCtD
Caffeine—Renal failure—Methotrexate—bone cancer	0.000258	0.00736	CcSEcCtD
Caffeine—Hyperglycaemia—Epirubicin—bone cancer	0.000249	0.00709	CcSEcCtD
Caffeine—Infestation NOS—Epirubicin—bone cancer	0.000246	0.00701	CcSEcCtD
Caffeine—Infestation—Epirubicin—bone cancer	0.000246	0.00701	CcSEcCtD
Caffeine—Renal failure—Epirubicin—bone cancer	0.000242	0.00689	CcSEcCtD
Caffeine—Haemoglobin—Methotrexate—bone cancer	0.000237	0.00676	CcSEcCtD
Caffeine—Haemorrhage—Methotrexate—bone cancer	0.000236	0.00672	CcSEcCtD
Caffeine—PDE4B—tendon—bone cancer	0.000233	0.0158	CbGeAlD
Caffeine—Hyperglycaemia—Doxorubicin—bone cancer	0.00023	0.00656	CcSEcCtD
Caffeine—Infestation NOS—Doxorubicin—bone cancer	0.000228	0.00648	CcSEcCtD
Caffeine—Infestation—Doxorubicin—bone cancer	0.000228	0.00648	CcSEcCtD
Caffeine—PDE4B—bone marrow—bone cancer	0.000226	0.0153	CbGeAlD
Caffeine—Hypersensitivity—Cisplatin—bone cancer	0.000225	0.00641	CcSEcCtD
Caffeine—PDE4B—spinal cord—bone cancer	0.000225	0.0152	CbGeAlD
Caffeine—Renal failure—Doxorubicin—bone cancer	0.000224	0.00637	CcSEcCtD
Caffeine—Haemoglobin—Epirubicin—bone cancer	0.000222	0.00632	CcSEcCtD
Caffeine—Haemorrhage—Epirubicin—bone cancer	0.000221	0.00629	CcSEcCtD
Caffeine—Cardiac disorder—Methotrexate—bone cancer	0.000219	0.00624	CcSEcCtD
Caffeine—Immune system disorder—Methotrexate—bone cancer	0.000213	0.00607	CcSEcCtD
Caffeine—Malnutrition—Methotrexate—bone cancer	0.000205	0.00585	CcSEcCtD
Caffeine—Haemoglobin—Doxorubicin—bone cancer	0.000205	0.00585	CcSEcCtD
Caffeine—Cardiac disorder—Epirubicin—bone cancer	0.000205	0.00584	CcSEcCtD
Caffeine—Haemorrhage—Doxorubicin—bone cancer	0.000204	0.00582	CcSEcCtD
Caffeine—CYP1B1—tendon—bone cancer	0.0002	0.0135	CbGeAlD
Caffeine—Immune system disorder—Epirubicin—bone cancer	0.0002	0.00568	CcSEcCtD
Caffeine—Rash—Cisplatin—bone cancer	0.000193	0.00549	CcSEcCtD
Caffeine—Dermatitis—Cisplatin—bone cancer	0.000193	0.00548	CcSEcCtD
Caffeine—Malnutrition—Epirubicin—bone cancer	0.000192	0.00548	CcSEcCtD
Caffeine—Cardiac disorder—Doxorubicin—bone cancer	0.00019	0.0054	CcSEcCtD
Caffeine—Nervousness—Epirubicin—bone cancer	0.000187	0.00532	CcSEcCtD
Caffeine—Immune system disorder—Doxorubicin—bone cancer	0.000185	0.00526	CcSEcCtD
Caffeine—Convulsion—Methotrexate—bone cancer	0.000178	0.00507	CcSEcCtD
Caffeine—Malnutrition—Doxorubicin—bone cancer	0.000178	0.00507	CcSEcCtD
Caffeine—Agitation—Epirubicin—bone cancer	0.000177	0.00503	CcSEcCtD
Caffeine—Nervousness—Doxorubicin—bone cancer	0.000173	0.00492	CcSEcCtD
Caffeine—Convulsion—Epirubicin—bone cancer	0.000167	0.00474	CcSEcCtD
Caffeine—Infection—Methotrexate—bone cancer	0.000167	0.00474	CcSEcCtD
Caffeine—Hypertension—Epirubicin—bone cancer	0.000166	0.00473	CcSEcCtD
Caffeine—Nervous system disorder—Methotrexate—bone cancer	0.000164	0.00468	CcSEcCtD
Caffeine—Agitation—Doxorubicin—bone cancer	0.000164	0.00466	CcSEcCtD
Caffeine—Skin disorder—Methotrexate—bone cancer	0.000163	0.00464	CcSEcCtD
Caffeine—Infection—Epirubicin—bone cancer	0.000156	0.00444	CcSEcCtD
Caffeine—Convulsion—Doxorubicin—bone cancer	0.000154	0.00439	CcSEcCtD
Caffeine—Nervous system disorder—Epirubicin—bone cancer	0.000154	0.00438	CcSEcCtD
Caffeine—Hypertension—Doxorubicin—bone cancer	0.000154	0.00437	CcSEcCtD
Caffeine—Tachycardia—Epirubicin—bone cancer	0.000153	0.00436	CcSEcCtD
Caffeine—Skin disorder—Epirubicin—bone cancer	0.000152	0.00434	CcSEcCtD
Caffeine—Dyspnoea—Methotrexate—bone cancer	0.00015	0.00426	CcSEcCtD
Caffeine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000145	0.00412	CcSEcCtD
Caffeine—Infection—Doxorubicin—bone cancer	0.000144	0.00411	CcSEcCtD
Caffeine—Nervous system disorder—Doxorubicin—bone cancer	0.000142	0.00406	CcSEcCtD
Caffeine—Tachycardia—Doxorubicin—bone cancer	0.000142	0.00404	CcSEcCtD
Caffeine—Skin disorder—Doxorubicin—bone cancer	0.000141	0.00402	CcSEcCtD
Caffeine—Dyspnoea—Epirubicin—bone cancer	0.00014	0.00398	CcSEcCtD
Caffeine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000135	0.00386	CcSEcCtD
Caffeine—Dyspnoea—Doxorubicin—bone cancer	0.000129	0.00369	CcSEcCtD
Caffeine—CYP2E1—tendon—bone cancer	0.000129	0.00871	CbGeAlD
Caffeine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000125	0.00357	CcSEcCtD
Caffeine—CYP2E1—spinal cord—bone cancer	0.000124	0.0084	CbGeAlD
Caffeine—Hypersensitivity—Methotrexate—bone cancer	0.000124	0.00352	CcSEcCtD
Caffeine—Hypersensitivity—Epirubicin—bone cancer	0.000116	0.00329	CcSEcCtD
Caffeine—Hypersensitivity—Doxorubicin—bone cancer	0.000107	0.00305	CcSEcCtD
Caffeine—Rash—Methotrexate—bone cancer	0.000106	0.00301	CcSEcCtD
Caffeine—Dermatitis—Methotrexate—bone cancer	0.000106	0.00301	CcSEcCtD
Caffeine—Rash—Epirubicin—bone cancer	9.9e-05	0.00282	CcSEcCtD
Caffeine—Dermatitis—Epirubicin—bone cancer	9.89e-05	0.00282	CcSEcCtD
Caffeine—Rash—Doxorubicin—bone cancer	9.16e-05	0.00261	CcSEcCtD
Caffeine—Dermatitis—Doxorubicin—bone cancer	9.15e-05	0.00261	CcSEcCtD
Caffeine—ABCB1—bone marrow—bone cancer	7.1e-05	0.00481	CbGeAlD
Caffeine—ABCB1—spinal cord—bone cancer	7.07e-05	0.00479	CbGeAlD
Caffeine—PIK3CB—Adaptive Immune System—MDM2—bone cancer	5.03e-05	0.000141	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by NGF—EGFR—bone cancer	4.95e-05	0.000139	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—IL3—bone cancer	4.93e-05	0.000138	CbGpPWpGaD
Caffeine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	4.89e-05	0.000137	CbGpPWpGaD
Caffeine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	4.89e-05	0.000137	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—GRM1—bone cancer	4.78e-05	0.000134	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—DHFR—bone cancer	4.78e-05	0.000134	CbGpPWpGaD
Caffeine—PRKDC—Immune System—JUN—bone cancer	4.76e-05	0.000134	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—GNA11—bone cancer	4.74e-05	0.000133	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—IL3—bone cancer	4.73e-05	0.000133	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—GNA11—bone cancer	4.69e-05	0.000132	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—NDUFA12—bone cancer	4.67e-05	0.000131	CbGpPWpGaD
Caffeine—CYP1A2—Biological oxidations—GSTP1—bone cancer	4.64e-05	0.00013	CbGpPWpGaD
Caffeine—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	4.57e-05	0.000129	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—JUN—bone cancer	4.56e-05	0.000128	CbGpPWpGaD
Caffeine—ADORA2A—Circadian rythm related genes—TP53—bone cancer	4.55e-05	0.000128	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.49e-05	0.000126	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—NT5C3A—bone cancer	4.48e-05	0.000126	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—NT5C3A—bone cancer	4.47e-05	0.000126	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—GNA11—bone cancer	4.46e-05	0.000125	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—KIT—bone cancer	4.45e-05	0.000125	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—ATF1—bone cancer	4.4e-05	0.000124	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—GSTP1—bone cancer	4.39e-05	0.000123	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—ATF1—bone cancer	4.36e-05	0.000123	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—SMO—bone cancer	4.36e-05	0.000123	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—SMO—bone cancer	4.31e-05	0.000121	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IL3—bone cancer	4.29e-05	0.000121	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IL3—bone cancer	4.26e-05	0.00012	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—NT5C3A—bone cancer	4.22e-05	0.000119	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TGFBR2—bone cancer	4.21e-05	0.000118	CbGpPWpGaD
Caffeine—PIK3CA—Disease—TGFBR2—bone cancer	4.13e-05	0.000116	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—MDM2—bone cancer	4.13e-05	0.000116	CbGpPWpGaD
Caffeine—PIK3CD—Innate Immune System—EGFR—bone cancer	4.11e-05	0.000116	CbGpPWpGaD
Caffeine—PIK3CD—Disease—KIT—bone cancer	4.11e-05	0.000115	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by NGF—EGFR—bone cancer	4.09e-05	0.000115	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—SMO—bone cancer	4.08e-05	0.000115	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—NDUFA12—bone cancer	4.07e-05	0.000114	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—CYP3A4—bone cancer	4.05e-05	0.000114	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.03e-05	0.000113	CbGpPWpGaD
Caffeine—ATM—Cell Cycle—TP53—bone cancer	4.01e-05	0.000113	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—GNA11—bone cancer	3.99e-05	0.000112	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—MDM2—bone cancer	3.97e-05	0.000111	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—IGF1R—bone cancer	3.96e-05	0.000111	CbGpPWpGaD
Caffeine—PIK3CD—Adaptive Immune System—EGFR—bone cancer	3.95e-05	0.000111	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—GNA11—bone cancer	3.94e-05	0.000111	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—KIT—bone cancer	3.88e-05	0.000109	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	3.87e-05	0.000109	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—NT5C3A—bone cancer	3.87e-05	0.000109	CbGpPWpGaD
Caffeine—PIK3CD—Disease—BRAF—bone cancer	3.86e-05	0.000108	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—NDUFA12—bone cancer	3.84e-05	0.000108	CbGpPWpGaD
Caffeine—PIK3CD—Hemostasis—TP53—bone cancer	3.83e-05	0.000108	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—NDUFA12—bone cancer	3.8e-05	0.000107	CbGpPWpGaD
Caffeine—PRKDC—Immune System—EGFR—bone cancer	3.74e-05	0.000105	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—GNA11—bone cancer	3.73e-05	0.000105	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—ATF1—bone cancer	3.71e-05	0.000104	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TGFBR2—bone cancer	3.67e-05	0.000103	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—ATF1—bone cancer	3.67e-05	0.000103	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TGFBR2—bone cancer	3.64e-05	0.000102	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL3—bone cancer	3.62e-05	0.000102	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—JUN—bone cancer	3.59e-05	0.000101	CbGpPWpGaD
Caffeine—PIK3CB—Innate Immune System—EGFR—bone cancer	3.58e-05	0.000101	CbGpPWpGaD
Caffeine—PIK3CB—Disease—KIT—bone cancer	3.58e-05	0.000101	CbGpPWpGaD
Caffeine—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.58e-05	0.000101	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL3—bone cancer	3.58e-05	0.0001	CbGpPWpGaD
Caffeine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.53e-05	9.92e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—MDM2—bone cancer	3.5e-05	9.84e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—ATF1—bone cancer	3.47e-05	9.75e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—GSTP1—bone cancer	3.46e-05	9.73e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—IGF1R—bone cancer	3.46e-05	9.71e-05	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—EGFR—bone cancer	3.44e-05	9.67e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IGF1R—bone cancer	3.42e-05	9.62e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL3—bone cancer	3.38e-05	9.51e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—NT5C3A—bone cancer	3.37e-05	9.48e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—SMO—bone cancer	3.37e-05	9.47e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—BRAF—bone cancer	3.36e-05	9.46e-05	CbGpPWpGaD
Caffeine—PIK3CB—Hemostasis—TP53—bone cancer	3.34e-05	9.39e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NDUFA12—bone cancer	3.25e-05	9.13e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—MDM2—bone cancer	3.23e-05	9.09e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—NT5C3A—bone cancer	3.18e-05	8.93e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—NT5C3A—bone cancer	3.15e-05	8.86e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—PTGS2—bone cancer	3.12e-05	8.76e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TGFBR2—bone cancer	3.09e-05	8.7e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—GNA11—bone cancer	3.08e-05	8.66e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TGFBR2—bone cancer	3.06e-05	8.59e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—KIT—bone cancer	3.05e-05	8.59e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—MDM2—bone cancer	3.05e-05	8.58e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—JUN—bone cancer	3.04e-05	8.56e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—ENO2—bone cancer	3e-05	8.44e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IGF1R—bone cancer	2.91e-05	8.18e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TGFBR2—bone cancer	2.89e-05	8.14e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IGF1R—bone cancer	2.88e-05	8.09e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—KIT—bone cancer	2.88e-05	8.08e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.87e-05	8.07e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—ATF1—bone cancer	2.86e-05	8.05e-05	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—EGFR—bone cancer	2.82e-05	7.93e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—KIT—bone cancer	2.82e-05	7.93e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—MDM2—bone cancer	2.82e-05	7.92e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL3—bone cancer	2.79e-05	7.85e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—DHFR—bone cancer	2.79e-05	7.83e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.77e-05	7.78e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IGF1R—bone cancer	2.72e-05	7.65e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—PTGS2—bone cancer	2.72e-05	7.64e-05	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—EGFR—bone cancer	2.71e-05	7.62e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—ENO2—bone cancer	2.71e-05	7.61e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—BRAF—bone cancer	2.7e-05	7.6e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NT5C3A—bone cancer	2.69e-05	7.57e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—JUN—bone cancer	2.65e-05	7.46e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—BRAF—bone cancer	2.65e-05	7.45e-05	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—TP53—bone cancer	2.63e-05	7.4e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—EGFR—bone cancer	2.62e-05	7.36e-05	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—PTGS2—bone cancer	2.61e-05	7.34e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—GNA11—bone cancer	2.6e-05	7.32e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—DHFR—bone cancer	2.51e-05	7.06e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NDUFA12—bone cancer	2.51e-05	7.05e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—KIT—bone cancer	2.51e-05	7.04e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.5e-05	7.01e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—KIT—bone cancer	2.48e-05	6.98e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—MDM2—bone cancer	2.41e-05	6.76e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—EGFR—bone cancer	2.39e-05	6.73e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TGFBR2—bone cancer	2.39e-05	6.72e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—CYP3A4—bone cancer	2.36e-05	6.64e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—BRAF—bone cancer	2.36e-05	6.62e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.35e-05	6.6e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—GNA11—bone cancer	2.35e-05	6.6e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—BRAF—bone cancer	2.33e-05	6.56e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—EGFR—bone cancer	2.28e-05	6.42e-05	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—PTGS2—bone cancer	2.28e-05	6.4e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—MDM2—bone cancer	2.26e-05	6.36e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—EGFR—bone cancer	2.26e-05	6.36e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IGF1R—bone cancer	2.25e-05	6.32e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—MDM2—bone cancer	2.22e-05	6.24e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—EGFR—bone cancer	2.21e-05	6.21e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—PTGS2—bone cancer	2.14e-05	6.02e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—CYP3A4—bone cancer	2.13e-05	5.99e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—KIT—bone cancer	2.11e-05	5.93e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—JUN—bone cancer	2.09e-05	5.88e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—KIT—bone cancer	2.09e-05	5.86e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—EGFR—bone cancer	2.09e-05	5.86e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NT5C3A—bone cancer	2.08e-05	5.84e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—GSTP1—bone cancer	2.02e-05	5.68e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—BRAF—bone cancer	1.98e-05	5.58e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—KIT—bone cancer	1.98e-05	5.55e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—MDM2—bone cancer	1.97e-05	5.55e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—JUN—bone cancer	1.97e-05	5.53e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ENO2—bone cancer	1.96e-05	5.52e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.96e-05	5.51e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—BRAF—bone cancer	1.96e-05	5.51e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ENO2—bone cancer	1.96e-05	5.5e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—MDM2—bone cancer	1.96e-05	5.5e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—EGFR—bone cancer	1.93e-05	5.41e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—EGFR—bone cancer	1.92e-05	5.41e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—MMP9—bone cancer	1.92e-05	5.38e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—EGFR—bone cancer	1.9e-05	5.34e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—BRAF—bone cancer	1.86e-05	5.22e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ENO2—bone cancer	1.85e-05	5.2e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—GSTP1—bone cancer	1.82e-05	5.12e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—DHFR—bone cancer	1.82e-05	5.12e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—DHFR—bone cancer	1.82e-05	5.11e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—EGFR—bone cancer	1.8e-05	5.06e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—PTGS2—bone cancer	1.79e-05	5.04e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—DHFR—bone cancer	1.72e-05	4.82e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—JUN—bone cancer	1.72e-05	4.82e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—GNA11—bone cancer	1.7e-05	4.78e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—JUN—bone cancer	1.7e-05	4.78e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—GNA11—bone cancer	1.7e-05	4.77e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ENO2—bone cancer	1.7e-05	4.77e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—MMP9—bone cancer	1.67e-05	4.69e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MDM2—bone cancer	1.66e-05	4.67e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—MMP9—bone cancer	1.65e-05	4.65e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.65e-05	4.63e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—EGFR—bone cancer	1.64e-05	4.62e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MDM2—bone cancer	1.64e-05	4.62e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KIT—bone cancer	1.63e-05	4.58e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—GNA11—bone cancer	1.6e-05	4.51e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—DHFR—bone cancer	1.57e-05	4.42e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MDM2—bone cancer	1.56e-05	4.37e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—EGFR—bone cancer	1.55e-05	4.35e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CYP3A4—bone cancer	1.54e-05	4.34e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CYP3A4—bone cancer	1.54e-05	4.33e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—BRAF—bone cancer	1.53e-05	4.31e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—EGFR—bone cancer	1.52e-05	4.27e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—EGFR—bone cancer	1.49e-05	4.17e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ENO2—bone cancer	1.48e-05	4.15e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GNA11—bone cancer	1.47e-05	4.13e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—CYP3A4—bone cancer	1.45e-05	4.09e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.45e-05	4.07e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—JUN—bone cancer	1.45e-05	4.06e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—JUN—bone cancer	1.43e-05	4.01e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MMP9—bone cancer	1.41e-05	3.95e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ENO2—bone cancer	1.39e-05	3.91e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MMP9—bone cancer	1.39e-05	3.91e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ENO2—bone cancer	1.38e-05	3.88e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—DHFR—bone cancer	1.37e-05	3.85e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—JUN—bone cancer	1.35e-05	3.8e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—EGFR—bone cancer	1.35e-05	3.79e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—EGFR—bone cancer	1.34e-05	3.76e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CYP3A4—bone cancer	1.33e-05	3.75e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.33e-05	3.73e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—GSTP1—bone cancer	1.32e-05	3.71e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—GSTP1—bone cancer	1.32e-05	3.7e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MMP9—bone cancer	1.32e-05	3.7e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TP53—bone cancer	1.3e-05	3.65e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—DHFR—bone cancer	1.29e-05	3.63e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MDM2—bone cancer	1.28e-05	3.61e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GNA11—bone cancer	1.28e-05	3.6e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—DHFR—bone cancer	1.28e-05	3.6e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—GSTP1—bone cancer	1.24e-05	3.5e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GNA11—bone cancer	1.21e-05	3.39e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GNA11—bone cancer	1.2e-05	3.36e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ENO2—bone cancer	1.18e-05	3.32e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CYP3A4—bone cancer	1.16e-05	3.26e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GSTP1—bone cancer	1.14e-05	3.2e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—EGFR—bone cancer	1.14e-05	3.19e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TP53—bone cancer	1.13e-05	3.18e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—EGFR—bone cancer	1.12e-05	3.16e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TP53—bone cancer	1.12e-05	3.15e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—JUN—bone cancer	1.12e-05	3.14e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CYP3A4—bone cancer	1.09e-05	3.08e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—DHFR—bone cancer	1.09e-05	3.08e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MMP9—bone cancer	1.09e-05	3.05e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CYP3A4—bone cancer	1.09e-05	3.05e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.08e-05	3.03e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—EGFR—bone cancer	1.06e-05	2.99e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTGS2—bone cancer	1.05e-05	2.94e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GNA11—bone cancer	1.02e-05	2.87e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GSTP1—bone cancer	9.93e-06	2.79e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—bone cancer	9.54e-06	2.68e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTGS2—bone cancer	9.44e-06	2.65e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—bone cancer	9.43e-06	2.65e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GSTP1—bone cancer	9.36e-06	2.63e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GSTP1—bone cancer	9.28e-06	2.61e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP3A4—bone cancer	9.27e-06	2.61e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.23e-06	2.59e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ENO2—bone cancer	9.1e-06	2.56e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—bone cancer	8.93e-06	2.51e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—EGFR—bone cancer	8.77e-06	2.47e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—DHFR—bone cancer	8.45e-06	2.37e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GSTP1—bone cancer	7.93e-06	2.23e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GNA11—bone cancer	7.89e-06	2.22e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—bone cancer	7.37e-06	2.07e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTGS2—bone cancer	6.83e-06	1.92e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTGS2—bone cancer	6.82e-06	1.92e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTGS2—bone cancer	6.44e-06	1.81e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTP1—bone cancer	6.12e-06	1.72e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS2—bone cancer	5.91e-06	1.66e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS2—bone cancer	5.15e-06	1.45e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS2—bone cancer	4.85e-06	1.36e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS2—bone cancer	4.81e-06	1.35e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS2—bone cancer	4.11e-06	1.15e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS2—bone cancer	3.17e-06	8.91e-06	CbGpPWpGaD
